The Effects of COVID-19 on Patient Experience and Price Transparency

Video

Ogi Kwon, of R1 Revenue Cycle Management (RCM) offers insights on lessons learned from the COVID-19 pandemic and the future of price transparency.

The COVID-19 pandemic provides an opportunity for organizations to think about how they can be proactive and monitor new regulatory changes in real time, said Ogi Kwon, a manager in the regulatory team at R1 RCM's advisory and assurance department.

In this interview with Chief Healthcare Executive™, Kwon explains how he feels price transparency as a whole while be something that continues to be iterated upon going forward and how requirements could take different forms.

R1 RCM is a revenue cycle management company that offers technology-driven solutions to transform health care providers' patient experience and financial performance.


Newsletter

Get the latest hospital leadership news and strategies with Chief Healthcare Executive, delivering expert insights on policy, innovation, and executive decision-making.

Recent Videos
Image credit: ©tippapatt - stock.adobe.com
Images: ANA, ENA, AACN, and AONL
Image: AAMC
Image: Chief Healthcare Executive
Image: HSHS St. Vincent Children's Hospital
Image credit: ©Michael Flippo - stock.adobe.com
Image: The White House
Image: U.S. Dept. of Health & Human Services
Image: Johns Hopkins Medicine
Image credit: ©Shevchukandrey - stock.adobe.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.